e-learning
resources
Virtual 2021
06.09.2021
Interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Progressive fibrosing ILDs
M. Kolb (Hamilton (ON), Canada)
Source:
Virtual Congress 2021 – Interstitial lung diseases
Session:
Interstitial lung diseases
Session type:
State of the art session
Number:
1534
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kolb (Hamilton (ON), Canada). Progressive fibrosing ILDs. Virtual Congress 2021 – Interstitial lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
How should we approach the treatment of progressive fibrosing ILDs?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019
Prevalence of progressive fibrosing interstitial lung disease
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Genetic susceptibilty and manifestation of progressive fibrosing interstitial lung diseases.
Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis
Year: 2020
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
Source: Eur Respir J, 54 (3) 1900161; 10.1183/13993003.00161-2019
Year: 2019
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001
The natural history of progressive fibrosing interstitial lung diseases
Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020
Year: 2020
Induced sputum MMPs in scleroderma fibrosing alveolitis
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006
Lung cancer in patients with cryptogenic fibrosing alveolitis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Specific features of the course of cryptogenic fibrosing alveolitis in pregnancy
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001
Drug-induced ILDs
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
The features of the course of cryptogenic fibrosing alveolitis in women
Source: Eur Respir J 2002; 20: Suppl. 38, 59s
Year: 2002
Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002
Sputum eosinophilia in cryptogenic fibrosing alveolitis
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014
Idiopatic fibrosing alveolitis functional respiratory disorders in children
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014
Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Airway centered interstitial fibrosis – An under-recognized type of idiopathic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept